ZACHARON PHARMACEUTICALS
Zacharon Pharmaceuticals is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans. Zacharon was incorporated in 2004 and has received initial funding through NIH grants and individual investors. Series A financing was more recently provided by Avalon Ventures, a long-standing San Diego-based venture capital firm with a focus on early stage life science companies. With this strong financial backing and innovative drug development platform in place, Zacharon is developing an entirely new class of human therapeutics addressing substantial unmet needs.
ZACHARON PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Developer Platform Health Care Therapeutics
Founded:
2004-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.zacharon.com
Total Employee:
1+
Status:
Active
Contact:
858-459-9750
Email Addresses:
[email protected]
Total Funding:
4.03 M USD
Technology used in webpage:
Cloudflare Hosting
Similar Organizations
Alaya Bioscience
Alaya Bioscience is a biotech company that develops novel nanotherapeutics for the treatment of human diseases.
Boston Biomedical
Boston Biomedical focuses on the research and development of novel therapeutics to treat cancer.
Coho Therapeutics
Coho Therapeutics is a biotechnology company that develops molecular glue therapeutics.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Enosi Life Sciences
Enosi Life Sciences is a drug research and development company providing therapeutics for autoimmune diseases and cancer.
NEUVOGEN
NEUVOGEN is applying a systems biology approach to develop whole-cell therapeutic cancer vaccines.
Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Theron Pharmaceuticals
Theron Pharmaceuticals is a biotechnology company that develops therapeutic products for the treatment of chronic respiratory diseases.
Current Employees Featured
Investors List
Avalon Ventures
Avalon Ventures investment in Series A - Zacharon Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Zacharon Pharmaceuticals
Official Site Inspections
http://www.zacharon.com
- Host name: 172.67.201.29
- IP address: 172.67.201.29
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zacharon Pharmaceuticals"
Zacharon Pharmaceuticals
Zacharon Pharmaceuticals, Inc. is a biotechnology company founded on opportunities to discover first-in-class small molecule drugs that target glycans. Zacharon was incorporated in 2004 and …See details»
Zacharon Pharmaceuticals | Company, Team
Zacharon Pharmaceuticals, Inc. is leveraging breakthrough drug discovery technology to develop an entirely new class of human therapeutics targeting glycans. This new class of small …See details»
Zacharon Pharmaceuticals - Crunchbase Company Profile & Funding
Zacharon Pharmaceuticals is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans. Zacharon was incorporated in 2004 and has …See details»
Zacharon Pharmaceuticals
Zacharon Pharmaceuticals, Inc. is leveraging breakthrough drug discovery technology to develop an entirely new class of human therapeutics targeting glycans. This new class of small …See details»
Zacharon Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Zacharon Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 3 literature, Drug:ZP-10395, AP-10295, ZP-10000 (Zacharon ...See details»
Zacharon Pharmaceuticals Inc - Company Profile and News
Company profile page for Zacharon Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Zacharon Pharmaceuticals - PitchBook
Zacharon Pharmaceuticals was acquired on 04-Jan-2013. Who acquired Zacharon Pharmaceuticals? Zacharon Pharmaceuticals was acquired by BioMarin Pharmaceutical. Data …See details»
Zacharon Pharmaceuticals - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Zacharon Pharmaceuticals - Products, Competitors, Financials, …
Zacharon Pharmaceuticals is leveraging glycobiology expertise to develop a new class of human therapeutics targeting glycans, the carbohydrate portions of glycoproteins, proteoglycans, and …See details»
Zacharon Pharmaceuticals - Overview, News & Similar companies ...
Zacharon Pharmaceuticals Inc. is a biotechnology company focused on early stage development of a new class of small-molecule drugs that target glyc ans. Glycans are a diverse class of …See details»
Zacharon Pharmaceuticals | Company, Management Team
Zacharon Pharmaceuticals, Inc. is leveraging breakthrough drug discovery technology to develop an entirely new class of human therapeutics targeting glycans. This new class of small …See details»
Zacharon Pharmaceuticals - Contacts, Employees, Board Members, …
Zacharon Pharmaceuticals employs its glycobiology expertise to develop a new class of human therapeutics targeting glycans.See details»
Zacharon Pharmaceuticals Announces Research and Development …
Apr 7, 2011 Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, …See details»
210M Pfizer Deal Validates Small Firm – BIOTECH: Big Pharma …
Apr 18, 2011 Zacharon was actively seeking a partner that would be able to take its small-molecule therapies through clinical testing and into medical settings, Jackman said. Pfizer, …See details»
BioMarin acquires Zacharon Pharma for upfront $10 million
Jan 8, 2013 The costs to be incurred in 2013 of acquiring Zacharon and absorbing its operations is covered by the previously provided 2013 R&D expense guidance. Lead program focused on …See details»
Zacharon Pharmaceuticals
From 2004 until joining Zacharon he was at the biotechnology company Vical, initially as Vice President of Business Development where he formed a partnership for the company’s lead …See details»
Zacharon Pharmaceuticals Announces Research and Development ...
Zacharon that have promising technologies to help develop treatments for rare diseases. Zacharon is an ideal partner, and we look forward to working with them to develop treatments …See details»
Zhakaron.com
The home to everything Zhakaron; at least that's what I tell people. Mostly a dumping ground for lists, blogs, and documents from YouTube/Twitch/Social media.See details»
Zacharon Pharmaceuticals | News and Publications
Zacharon Pharmaceuticals, Inc. is leveraging breakthrough drug discovery technology to develop an entirely new class of human therapeutics targeting glycans. This new class of small …See details»
Zacharon Pharmaceuticals Announces Research and Development ...
Apr 7, 2011 Zacharon Pharmaceuticals, Inc. is a biotechnology company leveraging unique glycobiology expertise to develop a new class of human therapeutics targeting the …See details»